Literature DB >> 31396925

Flow Cytometry Analysis to Identify Human CD4+ T Cell Subsets.

Jacqueline Flynn1,2,3, Paul Gorry4.   

Abstract

Flow cytometry is a powerful tool, which uses lasers to analyze a wide range of different characteristics of cells. It is commonly used to determine the expression of cell surface markers and intracellular molecules to define cells into different populations using cell size, granularity, and fluorescently labeled antibodies. Thus, flow cytometry enables simultaneous and mutliparameter analysis of single cells.During the staining procedure, a single cell suspension is created for staining with flow cytometry antibodies for analysis on the flow cytometer. The staining methods from this technique can be used for different cell types by changing the surface marker targeted by the flow antibody, provided all antibodies are titrated prior to use, and are chosen with knowledge of the density of surface molecule for detection and brightness of fluorochrome to guide antibody selection.This chapter's protocol has been designed specifically for detection of human CD4+ T cell subsets defining naïve and memory subpopulations by surface marker phenotyping.

Entities:  

Keywords:  CD markers; CD4+ T cells; Flow cytometry; Memory T cells; Naïve T cells; T cell subsets

Mesh:

Substances:

Year:  2019        PMID: 31396925     DOI: 10.1007/978-1-4939-9728-2_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Circular RNA 0001666 inhibits colorectal cancer cell proliferation, invasion and stemness by inactivating the Wnt/β-catenin signaling pathway and targeting microRNA-1229.

Authors:  Fei Bai; Chaohui Zuo; Yongzhong Ouyang; Ke Xiao; Zhuo He; Zhi Yang
Journal:  Oncol Lett       Date:  2022-03-16       Impact factor: 3.111

2.  Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients.

Authors:  Yuanyuan Li; Bingbin Dong; Wei Wu; Jiawei Wang; Hao Jin; Kangmei Chen; Kangling Huang; Songyin Huang; Yandan Yao
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.